hepat
c
viru
hcv
bloodborn
pathogen
caus
acut
chronic
hepat
signific
number
peopl
chronic
infect
hcv
develop
cirrhosi
andor
liver
cancer
pathophysiolog
mechan
hepatocyt
damag
associ
chronic
hcv
infect
fulli
understood
yet
mainli
due
lack
vitro
system
abl
recapitul
stage
infect
vivo
sever
studi
underlin
hcv
viru
replic
depend
redoxsensit
cellular
pathway
addit
known
viru
induc
alter
cellular
redox
state
howev
exact
interplay
hcv
replic
oxid
stress
elucid
particular
role
reduc
glutathion
gsh
hcv
replic
infect
still
clear
set
vitro
system
base
low
moi
cell
line
hcv
infecti
clone
reproduc
acut
persist
phase
hcv
infect
day
cultur
demonstr
acut
phase
hcv
infect
character
elev
level
reactiv
oxygen
speci
ro
associ
part
increas
nadphoxidas
transcript
activ
deplet
gsh
accompani
high
rate
viral
replic
apoptot
cell
death
convers
chronic
phase
character
reestablish
reduc
environ
due
decreas
ro
product
increas
gsh
content
infect
cell
might
concur
establish
viral
persist
treatment
prooxid
auranofin
persist
infect
cultur
induc
increas
viral
rna
titer
suggest
prooxid
state
could
favor
reactiv
hcv
viral
replic
turn
caus
cell
damag
death
result
suggest
target
redoxsensit
hostcel
pathway
essenti
viral
replic
andor
persist
may
repres
promis
option
contrast
hcv
infect
hepat
c
viru
hcv
rna
viru
belong
flavivirida
famili
repres
major
worldwid
concern
caus
death
worldwid
everi
year
hcv
replic
cycl
take
place
cytoplasm
compart
hepatocyt
caus
acut
chronic
hepat
persist
hcv
infect
clinic
character
lifelong
lowlevel
viru
product
accompani
develop
chronic
liver
infect
infect
patient
evolv
steatosi
fibrosi
cirrhosi
small
percentag
chronic
infect
patient
develop
endstag
hepatocellular
carcinoma
although
exact
molecular
mechan
underli
hcvrelat
liver
injuri
fulli
understood
redox
alter
hepatocyt
extens
describ
sever
chronic
liver
diseas
oxid
stress
imbal
reactiv
oxygen
speci
ro
product
clearanc
scaveng
molecul
recogn
lead
factor
induc
hepatocyt
death
inflamm
fibrogenesi
respons
induct
perpetu
liver
damag
sever
author
report
rise
ro
level
hcv
infect
variou
viral
protein
known
induc
andor
augment
ro
product
includ
hcv
core
nonstructur
ns
moreov
simultan
induct
sever
rosproduc
pathway
enzym
endoplasm
reticulum
er
oxidoreductas
nadph
nicotinamid
adenin
dinucleotid
phosphat
oxidas
nox
also
contribut
hcvinduc
oxid
stress
contrari
studi
report
increas
antioxid
defens
superoxid
dismutas
sod
peroxiredoxin
prdx
glutathion
stransferas
gst
enzym
activ
gsh
level
glutathion
import
radic
scaveng
directli
indirectli
neutral
varieti
reactiv
molecul
superoxid
anion
hydroxyl
radic
hydrogen
peroxid
h
ratio
reduc
gsh
oxid
gssg
form
gsh
consid
import
indic
antioxid
capac
cell
conflict
result
shown
effect
hcv
intracellular
gsh
metabol
inde
roe
collabor
report
signific
rais
gssg
hcvinfect
cell
increas
gsh
concentr
demonstr
de
mochel
et
al
use
vitro
infect
system
interestingli
abdalla
et
al
describ
differ
effect
two
viral
protein
cell
antioxid
defens
fact
hepatocyt
overexpress
hcv
core
protein
reduc
gsh
level
increas
oxid
thioredoxin
trx
overexpress
viral
protein
known
abil
caus
oxid
stress
increas
antioxid
enzym
mnsod
catalas
heme
gsh
content
final
patient
chronic
hepat
c
show
deplet
gsh
content
increas
antioxid
treatment
howev
differ
genotyp
hcv
exhibit
differ
abil
induc
oxid
stress
fact
patient
chronic
infect
genotyp
sharp
decreas
reduc
gsh
level
observ
respect
genotyp
suggest
seriou
diseas
associ
genotyp
interestingli
de
novo
synthesi
gsh
control
transcript
factor
factor
regul
express
cytoprotect
gene
studi
demonstr
acut
hcv
infect
associ
earli
induct
protein
function
cellular
stress
respons
includ
oxid
stress
respons
hand
hcv
core
impair
signal
pathway
induc
transloc
smaf
protein
cytoplasm
bind
part
replic
complex
result
trap
cytoplasm
unabl
function
transcript
factor
basi
conflict
result
report
literatur
relationship
redox
balanc
hcv
infect
goal
studi
clarifi
whether
viru
abl
condit
redox
environ
infect
cell
order
induc
acut
infect
establish
persist
cell
reason
set
vitro
system
mimic
close
possibl
acut
chronic
hcv
infect
demonstr
acut
phase
infect
hcv
replic
high
rate
thu
induc
intens
apoptosi
infect
cell
phase
mark
oxid
stress
regist
mainli
due
activ
decreas
gsh
consequ
gshgssg
ratio
convers
chronic
phase
infect
low
level
hcv
replic
apoptosi
observ
ro
product
return
basal
level
gsh
content
reestablish
gshgssg
ratio
shift
versu
reduc
form
gsh
moreov
treatment
hcvchronic
infect
cell
prooxid
drug
auranofin
abl
reactiv
viral
replic
cell
line
human
hepatoma
cell
gener
provid
dr
charl
rice
cell
grown
highglucos
dulbecco
modifi
eagl
medium
dmem
sigma
supplement
uml
penicillin
streptomycin
nonessenti
amino
acid
fetal
bovin
serum
fb
invitrogen
co
viru
stock
use
studi
prepar
describ
plasmid
encod
entir
viral
genom
chimer
strain
hcv
genotyp
kindli
provid
c
rice
plasmid
linear
xbai
digest
treat
mung
bean
nucleas
remov
end
overhang
linear
dna
templat
first
purifi
phenol
chloroform
extract
ethanol
precipit
transcrib
rna
polymeras
use
kit
ambion
austin
tx
accord
manufactur
protocol
electropor
cell
grown
confluenc
trypsin
wash
twice
cold
pb
resuspend
cold
pb
concentr
cellsml
ml
aliquot
mix
vitro
transcrib
rna
dispens
cm
gene
pulser
cuvett
biorad
sampl
puls
use
gene
pulser
apparatu
biorad
hercul
ca
singl
puls
kv
mf
cell
resuspend
ml
complet
growth
medium
plate
incub
co
rel
humid
cell
split
everi
day
viru
infect
measur
immunofluoresc
assay
describ
express
tcdi
ml
cultur
supernat
th
passag
use
infect
cell
multipl
infect
moi
serumfre
highglucos
dmem
hour
medium
remov
replac
complet
medium
day
passag
supernat
collect
centrifug
rpm
min
clear
debri
filtrat
pore
size
filter
store
viru
stock
infect
viral
titer
assay
cell
plate
grown
h
challeng
viru
stock
serumfre
medium
moi
cultur
supernat
uninfect
cell
serv
control
mock
prepar
cell
incub
presenc
viru
h
viral
challeng
mockinfect
virusinfect
cell
wash
pb
cultur
fresh
medium
contain
fb
titer
infecti
hcv
determin
tissu
cultur
infect
dose
tcid
assay
cell
supernat
serial
dilut
complet
dmem
use
infect
well
cell
plate
well
per
dilut
level
hcv
infect
determin
three
day
postinfect
immunofluoresc
stain
hcv
core
protein
well
show
posit
stain
hcv
core
protein
count
tcid
titer
interpol
use
reedmuench
method
sigmaaldrich
heidelberg
germani
compound
dissolv
dimethylsulfoxid
dmso
appli
cell
final
concentr
nm
concentr
toxic
effect
observ
highest
dmso
concentr
present
cultur
medium
control
cell
treat
equival
concentr
vehicl
cytotox
assay
cytotox
auranofin
determin
cell
count
cell
viabil
assess
trypan
blue
dye
exclus
test
immunofluoresc
assay
cell
fix
methanol
aceton
vv
min
block
pb
contain
bovin
serum
albumin
bsa
least
min
cell
incub
mous
monoclon
antihepat
c
viru
core
antibodi
abcam
ab
bound
antibodi
reveal
mous
antihuman
igg
conjug
alexa
fluor
life
technolog
wash
nuclei
stain
dapi
molecular
probe
pb
min
room
temperatur
fluoresc
imag
acquir
olympu
microscop
equip
nanomov
softworx
deltavis
imag
acquisit
softwar
appli
precis
wa
usa
uplanapo
object
imag
captur
constant
exposur
time
gain
offset
blot
cell
detach
wash
cold
pb
centrifug
g
min
pellet
lyse
cold
ripa
lysi
buffer
mm
tri
ph
mm
nacl
tritonx
sd
sodium
deoxychol
contain
proteas
phosphatas
inhibitor
min
ice
lysat
centrifug
g
min
remov
debri
protein
concentr
cell
extract
determin
bradford
method
biorad
lysat
resolv
sdspage
blot
onto
nitrocellulos
membran
membran
block
nonfat
dri
milk
trisbuff
salin
contain
h
room
temperatur
rt
incub
specif
primari
antibodi
use
final
concentr
antibodi
use
follow
rabbit
polyclon
santa
cruz
biotechnolog
rabbit
polyclon
abcam
rabbit
monoclon
cell
signal
technolog
euroclon
pero
mi
itali
mous
monoclon
antitubulin
sigmaaldrich
mous
monoclon
antilamin
ac
sigmaaldrich
immunocomplex
detect
peroxidasecoupl
secondari
antibodi
jackson
follow
enhanc
chemiluminesc
ge
healthcar
life
scienc
densitometri
done
use
quantiti
one
analysi
softwar
biorad
glutathion
assay
measur
total
intracellular
glutathion
tgsh
includ
reduc
oxid
form
gsh
gssg
respect
gssg
perform
mean
cayman
gsh
assay
kit
cayman
chemic
co
accord
manufactur
instruct
briefli
confluent
control
infect
cell
wash
twice
pb
harvest
use
rubber
policeman
homogen
freezethaw
method
ml
mm
me
buffer
ph
contain
mm
edta
centrifug
small
amount
supernat
use
protein
assay
biorad
protein
assay
residu
supernat
deprotein
ad
equal
amount
wv
metaphosphor
acid
centrifug
min
supernat
neutral
triethanolamin
per
ml
sampl
tgsh
level
determin
endpoint
method
read
absorb
nm
min
accord
procedur
recommend
manufactur
anoth
experi
gsh
mask
h
assay
determin
gssg
level
sampl
tgsh
gssg
determin
comparison
standard
normal
protein
content
express
nmolmg
protein
gsh
content
obtain
subtract
gssg
tgsh
cell
death
determin
quantit
evalu
apoptosi
perform
doublestain
flow
cytometri
method
use
fluorescein
isothiocyan
fitc
conjug
annexin
v
av
propidium
iodid
pi
apoptosi
detect
kit
marin
biolog
laboratori
mbl
wood
hole
usa
accord
manufactur
protocol
allow
discrimin
among
earli
apoptot
late
apoptot
necrot
cell
ro
assay
ro
product
determin
mean
cellrox
deep
red
reagent
thermo
fisher
fluorogen
probe
describ
manufactur
instruct
cellrox
ad
cell
cultur
incub
minut
cell
fix
paraformaldehyd
sampl
immedi
analyz
lr
ii
cytomet
becton
dickinson
san
jose
ca
usa
equip
argon
laser
uvb
laser
data
obtain
analyz
diva
softwar
b
median
valu
fluoresc
intens
histogram
use
provid
semiquantit
assess
ro
product
sampl
acquir
facscalibur
cytomet
bd
bioscienc
equip
argon
laser
red
diod
laser
least
event
acquir
data
record
statist
analyz
macintosh
comput
use
cellquest
softwar
bd
bioscienc
median
valu
fluoresc
intens
histogram
use
provid
semiquantit
assess
ro
product
realtim
rtpcr
analysi
total
rna
isol
control
hcvinfect
cell
harvest
indic
time
pi
rneasi
kit
qiagen
accord
manufactur
instruct
isol
rna
revers
transcrib
cdna
use
cdna
synthesi
kit
biorad
compar
realtim
pcr
analysi
gene
express
perform
sybr
green
supermix
biorad
analyz
lightcycl
biorad
follow
forward
revers
primer
use
housekeep
dehydrogenas
gapdh
use
normal
rel
quantit
evalu
perform
compar
method
result
present
fold
increas
rel
control
cell
dissoci
curv
gener
ensur
singl
amplicon
produc
product
intracellular
viral
rna
assess
quantit
onestep
rtpcr
carri
use
abi
realtim
pcr
system
appli
biosystem
total
rna
mix
taqman
onestep
rtpcr
master
mix
abi
forward
tcccgggagag
ccatagt
revers
primer
cccagtcttcccgg
caatt
nm
probe
famcaccggttccg
cagacc
tamra
vitro
transcrib
genotyp
rna
use
standard
quantifi
copi
number
viral
rna
statist
signific
evalu
use
graphpad
san
diego
ca
usa
softwar
version
data
report
verifi
least
independ
experi
report
mean
standard
deviat
sd
test
detail
experi
describ
figur
legend
p
valu
consid
signific
model
acut
chronic
hcv
infect
attempt
set
hcv
infecti
cell
cultur
system
mimic
acut
chronic
hcv
infect
human
hepatocellular
carcinoma
cell
line
infect
hcv
low
moi
allow
multiplecycl
replic
describ
materi
method
cultur
day
viral
adsorpt
cell
cultur
viabil
monitor
differ
time
point
viral
replic
evalu
realtim
rtpcr
immunofluoresc
assay
hcv
core
protein
number
viral
core
posit
cell
estim
immunofluoresc
evalu
extens
hcvinfect
cell
first
two
passag
day
postinfect
cell
stain
hcv
core
protein
thu
indic
high
rate
hcv
replic
correspond
acut
phase
infect
figur
left
side
contrari
late
stage
infect
day
postinfect
pi
refer
chronic
phase
cell
express
core
protein
figur
right
side
similarli
hcv
rna
intracellular
compart
reach
highest
titer
total
rna
p
vs
day
pi
decreas
recoveri
phase
cell
cultur
chronic
phase
total
rna
day
pi
total
rna
day
pi
figur
b
consist
persist
infect
cell
cultur
furthermor
correspond
maximum
titer
hcv
rna
number
hcvinfect
cell
significantli
reduc
compar
uninfect
one
figur
c
fact
trypan
blue
dye
exclus
assay
show
signific
decreas
aliv
cell
socal
crisi
phase
last
two
week
infect
cultur
split
particularli
day
cell
becam
round
detach
plate
float
cultur
medium
data
shown
furthermor
fac
analysi
annexin
vpi
doubl
stain
cell
show
infect
cell
underw
apoptot
death
crisi
phase
fact
shown
figur
right
panel
percentag
doublestain
piav
cell
increas
respect
uninfect
cell
ctr
passag
increas
percentag
apoptot
cell
obtain
mean
independ
experi
detect
infect
cultur
day
pi
compar
uninfect
one
figur
right
panel
interestingli
apoptot
death
infect
cell
cultur
coincid
highest
intracellular
viral
rna
titer
figur
b
thu
suggest
caus
link
rate
hcv
replic
cell
death
subsequ
crisi
phase
cell
start
recoveri
phase
end
number
live
cell
hcvinfect
cultur
compar
control
cell
figur
c
see
valu
accordingli
fac
analysi
demonstr
day
pi
day
pi
percentag
apoptot
cell
return
control
valu
upon
recoveri
cultur
figur
right
panel
see
valu
moreov
time
point
day
pi
chronic
phase
percentag
hcv
coreposit
cell
decreas
figur
right
panel
vs
acut
phase
thu
mirror
viral
titer
trend
see
figur
b
result
strongli
suggest
steadi
state
level
hcv
replic
collect
result
demonstr
initi
infect
cell
low
moi
lead
obtain
acut
vitro
infect
featur
apoptot
death
infect
cell
name
acut
phase
latter
follow
recoveri
infect
cell
cultur
character
lower
viru
replic
subsequ
establish
persist
infect
name
chronic
phase
characterist
indic
vitro
model
persist
infect
set
activ
redox
chang
particular
increas
ro
level
associ
hcv
infect
nevertheless
impact
intracellular
hcv
replic
cellular
redox
environ
far
contradictori
aim
confluent
monolay
cell
infect
hcv
differ
time
point
viral
adsorpt
ro
product
measur
fac
use
rossensit
probe
cellrox
shown
figur
signific
increas
intracellular
ro
level
time
higher
compar
control
detect
infect
cell
day
pi
hcv
rna
reach
maximum
valu
maintain
high
level
apoptot
crisi
period
cell
cultur
recoveri
day
pi
ro
level
infect
cell
return
control
valu
figur
right
panel
result
suggest
intracellular
rosmedi
oxid
stress
induc
hcv
replic
simultan
accompani
apoptot
phase
next
investig
whether
model
increas
ro
level
associ
nox
activ
particularli
two
isoform
involv
sever
hcv
infect
aim
cell
infect
hcv
assay
mrna
rtpcr
differ
phase
hcv
infect
result
demonstr
mrna
level
doubl
day
pi
infect
cell
respect
uninfect
control
cell
mrna
level
decreas
return
physiolog
level
figur
b
consist
protein
express
upregul
infect
cell
acut
phase
decreas
chronic
phase
figur
c
similar
result
obtain
enzym
although
decreas
began
earlier
collect
data
suggest
nox
enzym
one
possibl
player
hcvinduc
ro
product
test
whether
cell
activ
gsh
antioxid
system
respons
hcvinduc
oxid
stress
intracellular
content
reduc
gsh
oxid
gssg
form
glutathion
measur
differ
time
hcv
infect
use
colorimetr
assay
shown
figur
earli
step
acut
phase
infect
gsh
content
diminish
p
p
day
pi
respect
compar
uninfect
cell
contrast
gsh
level
infect
cell
significantli
higher
cell
recoveri
compar
control
cell
maintain
higher
level
chronic
phase
interestingli
compar
acut
chronic
phase
signific
rise
trend
gsh
content
infect
cell
detect
latter
phase
vs
convers
shown
figur
b
gssg
level
increas
acut
phase
particular
content
doubl
day
pi
interestingli
shown
figur
c
gshgssg
ratio
physiolog
condit
maintain
shift
toward
oxid
form
viral
replic
reach
peak
figur
b
chronic
phase
ratio
indic
restor
physiolog
redox
environ
intracellular
gsh
regener
oxid
form
glutathion
reductas
gr
synthes
ex
novo
consecut
action
glutam
cystein
ligas
gcl
gsh
synthas
gs
therefor
evalu
transcript
express
enzym
acut
chronic
phase
infect
shown
figur
mrna
level
gr
strongli
upregul
earli
step
infect
gssg
level
high
gcl
gs
enzym
express
increas
start
end
acut
phase
recoveri
period
peak
gsh
content
detect
interestingli
enzym
still
activ
chronic
phase
suggest
necess
maintain
reduc
environ
longterm
cultur
final
decid
evalu
whether
enzym
control
pathway
therefor
analyz
protein
express
acut
chronic
phase
shown
figur
b
seem
downregul
viru
earli
phase
infect
express
late
infect
chronic
phase
wellestablish
result
suggest
oxid
stress
acut
phase
use
promot
viral
replic
reduc
condit
observ
chronic
phase
probabl
favor
viral
persist
cell
level
hcv
rna
copi
sinc
intracellular
redox
condit
seem
play
key
role
establish
chronic
phase
hcv
infect
decid
evalu
whether
oxid
stress
could
reactiv
hcv
replic
chronic
infect
cell
reason
chemic
treatment
auranofin
au
wellknown
prooxid
drug
induc
ro
product
infect
cell
use
experiment
model
treatment
au
nm
hr
abl
induc
increment
intracellular
ro
level
twofold
either
uninfect
ctr
hcvinfect
cell
figur
parallel
number
intracellular
hcv
rna
copi
autreat
cultur
greater
untreat
infect
cell
figur
b
interestingli
condit
hcvinfect
cell
cultur
underw
apoptosi
figur
c
suggest
oxid
stress
induct
could
favor
viral
replic
turn
caus
cell
damag
death
oxid
stress
emerg
key
contributor
develop
progress
hcvinduc
pathogenesi
liver
associ
develop
hepatocellular
carcinoma
lack
vitro
system
recapitul
differ
stage
hcv
chronic
infect
hamper
disclosur
exact
mechan
mutual
effect
hcv
infect
oxid
stress
pathway
host
cell
studi
abl
set
hcv
infecti
system
cell
permiss
infecti
clone
particularli
infect
cell
monolay
low
moi
hcv
allow
obtain
first
acut
infect
subsequ
establish
persist
infect
demonstr
acut
phase
high
percentag
infect
cell
underw
apoptosi
viral
titer
peak
wherea
chronic
phase
viral
replic
reduc
consequ
percentag
apoptoticinfect
cell
model
call
longterm
infect
cultur
ltic
could
mimic
stage
natur
hcv
infect
interest
hcv
long
believ
noncytopath
viru
hepatocyt
damag
infect
consid
mediat
immun
system
howev
consist
previous
report
result
could
demonstr
hcv
induc
cell
death
vitro
infect
cell
absenc
rigimedi
innat
immun
respons
presenc
low
number
core
express
cell
call
chronic
phase
parallel
low
level
viral
rna
titer
indic
abil
clone
hcv
persist
infect
suscept
cell
cultur
regard
mechan
involv
establish
vitro
persist
could
close
virushost
cell
interact
report
zhong
et
al
cell
longterm
infect
hcv
cell
resist
reinfect
due
loss
hcv
receptor
select
chronic
phase
viru
side
hcv
known
exist
quasispeci
patient
vivo
persist
infect
vitro
viru
variant
aris
adapt
cultur
abl
persist
without
kill
host
cell
reduc
infect
point
deserv
deeper
investig
futur
furthermor
hcv
acut
infect
ro
overproduct
mainli
mediat
nadphoxidas
regist
infect
cell
nox
famili
seven
enzym
gener
h
molecular
oxygen
accumul
evid
indic
noxmedi
ro
product
critic
role
hepat
fibrosi
particular
involv
sever
hcvassoci
liver
diseas
well
regul
viral
replic
differ
virus
found
rise
mirror
trend
ro
product
viral
replic
fact
express
increas
acut
phase
infect
decreas
late
infect
thu
suggest
critic
role
nox
also
regul
hcv
replic
cycl
reason
nox
enzym
downmodul
infect
cell
chronic
phase
still
unclear
hypothes
could
mechan
induc
viru
maintain
reduc
environ
host
cell
establish
persist
inde
virus
abl
time
posit
neg
modul
nox
isoform
advantag
studi
need
clarifi
aspect
noteworthi
mainli
local
nuclei
er
hcv
infect
amount
nucleu
increas
seem
one
mechan
underli
hcv
pathogenesi
therefor
also
possibl
specul
nuclear
may
increas
acut
phase
hcv
infect
experiment
system
thu
promot
dna
damag
apoptosi
infect
cell
apoptot
death
might
favor
viru
spread
throughout
cell
cultur
studi
progress
deepen
aspect
import
note
howev
nox
sourc
ro
product
hcvinfect
cell
fact
viral
protein
ie
core
shown
increas
ro
level
direct
indirect
interact
mitochondria
therefor
rule
ro
increas
hcvinfect
cell
might
part
produc
mitochondri
compart
nox
high
chemic
reactiv
ro
cell
possess
antioxid
defens
mechan
maintain
redox
homeostasi
whose
princip
compon
gsh
main
abund
intracellular
antioxid
play
crucial
role
sustain
redox
balanc
ratio
gsh
gssg
consid
good
indic
redox
environ
date
great
debat
induct
modul
oxid
stress
hcv
relationship
acut
chronic
phase
infect
hepatocyt
major
sourc
gsh
bodi
gsh
antioxid
system
play
import
role
oxid
stress
cell
interestingli
reduc
gsh
level
found
serum
liver
chronic
hcvinfect
patient
found
intracellular
gsh
level
significantli
decreas
infect
cell
acut
phase
gssg
increas
consequ
ratio
gshgssg
shift
toward
gssg
thu
reflect
impair
antioxid
potenti
oxid
environ
seem
necessari
hcv
replic
demonstr
viral
titer
peak
acut
phase
data
line
differ
vitro
studi
virus
respons
acut
infect
demonstr
role
virusinduc
oxid
stress
promot
viral
replic
contrari
chronic
phase
reduc
redox
environ
restor
increas
gsh
content
infect
cell
might
use
establish
viral
persist
inde
treatment
persist
hcvinfect
cell
prooxid
drug
auranofin
caus
reactiv
hcv
replic
mechan
hcv
manipul
redox
environ
advantag
fulli
clarifi
yet
known
gsh
de
novo
synthesi
driven
nuclear
factor
erythroid
factor
one
major
cellular
defens
mechan
oxid
stress
master
regul
differ
cytoprotect
gene
includ
involv
antioxid
gsh
pathway
recent
demonstr
higher
express
nuclear
contribut
persist
hcv
infect
knockdown
suppress
persist
infect
author
suggest
nuclear
transloc
might
play
import
role
express
gene
contribut
regul
apoptosi
hcv
persist
accordingli
found
higher
mrna
level
gcl
gs
enzym
recoveri
period
time
protein
content
highli
express
chronic
phase
basi
evid
suggest
high
gsh
level
regist
chronic
infect
cell
compar
measur
acut
phase
infect
might
partli
relat
activ
pathway
great
debat
regard
supplement
antioxid
combin
antivir
drug
fact
sever
clinic
trial
report
antioxid
therapi
decreas
viral
load
amelior
hepat
damag
howev
studi
report
supplement
vitamin
c
e
selenium
increas
antioxid
statu
effect
viral
load
oxid
marker
conflict
result
highlight
dark
side
antioxid
therefor
basi
evid
literatur
avail
suggest
care
consid
use
antioxid
chronic
hcvinfect
patient
sinc
although
could
limit
liver
tissu
injuri
would
contribut
establish
viru
persist
turn
contribut
develop
hepatocellular
carcinoma
lack
hcv
vaccin
emerg
viral
strain
resist
antivir
therapi
underlin
limit
current
weapon
use
fight
infect
recent
year
new
drug
act
specif
hcv
viral
protein
daa
develop
among
inhibitor
proteas
telaprevir
boceprevir
simeprevir
last
approv
rna
polymeras
inhibitor
sofosbuvir
sinc
emerg
drugresist
hcv
variant
recent
describ
urgent
need
identifi
novel
target
design
new
effect
therapeut
strategi
context
target
redoxsensit
hostcel
pathway
essenti
viral
replic
andor
persist
may
repres
promis
option
contrast
hcv
infect
conclus
demonstr
acut
phase
hcv
infect
character
mark
oxid
stress
similarli
virus
use
viral
replic
contrari
restor
reduc
redox
condit
character
chronic
phase
infect
might
play
key
role
decreas
viral
replic
apoptot
death
overal
data
indic
redox
sensit
pathway
control
differ
phase
hcv
infect
suggest
particular
wari
supplement
exogen
antioxid
chronic
hcvinfect
patient
potenti
role
favor
viral
persist
data
use
support
find
studi
avail
correspond
author
upon
request
author
declar
conflict
interest
